Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OPCH
OPCH logo

OPCH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Option Care Health Inc (OPCH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.990
1 Day change
1.29%
52 Week Range
36.800
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Option Care Health Inc (OPCH) is not a strong buy at the moment for a beginner investor with a long-term focus. While the stock has shown a slight recovery in price, the lack of significant positive catalysts, mixed analyst sentiment, and absence of strong trading signals suggest it is better to hold and monitor for now.

Technical Analysis

The MACD is positively expanding with a histogram of 0.322, indicating bullish momentum. However, the RSI at 71 is in the neutral zone, and moving averages are converging, suggesting no clear trend. The stock is trading close to its pivot level of 21.156, with resistance at 22.153 and support at 20.159.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
6

Positive Catalysts

  • No significant positive catalysts identified. The MACD indicates some bullish momentum, and the stock is slightly recovering from its recent drop.

Neutral/Negative Catalysts

  • Analysts have significantly lowered price targets, citing structural challenges, adverse chronic infusion dynamics, and increased competition. No recent news or significant insider or hedge fund activity to support a bullish case.

Financial Performance

No financial data available for the latest quarter. Analysts have described Q1 results as mixed, with strong acute growth but challenges in chronic inflammatory census.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets across the board, with ratings ranging from Hold to Buy. Concerns include structural pressures, competition, and steep guidance ramps. The average price target is significantly higher than the current price, but sentiment remains cautious.

Wall Street analysts forecast OPCH stock price to rise
10 Analyst Rating
Wall Street analysts forecast OPCH stock price to rise
9 Buy
1 Hold
0 Sell
Strong Buy
Current: 21.710
sliders
Low
27
Averages
36.22
High
40
Current: 21.710
sliders
Low
27
Averages
36.22
High
40
Morgan Stanley
Overweight
downgrade
$38 -> $28
AI Analysis
2026-05-06
Reason
Morgan Stanley
Price Target
$38 -> $28
AI Analysis
2026-05-06
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Option Care Health to $28 from $38 and keeps an Overweight rating on the shares.
JPMorgan
Overweight
downgrade
$40 -> $33
2026-05-04
Reason
JPMorgan
Price Target
$40 -> $33
2026-05-04
downgrade
Overweight
Reason
JPMorgan lowered the firm's price target on Option Care Health to $33 from $40 and keeps an Overweight rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OPCH
Unlock Now

People Also Watch